Planning Grant to Develop Phase III Clinical Trials for Lewy Body Dementia (R34 clinical Trial Not Allowed)

Funder: National Institutes of Health

Due Date: 3/20/2018

Budget: $750,000

Opportunity: RFA-NS-18-017

The purpose of this FOA is to provide one year of support for planning activities necessary for initiating a Phase III clinical trial designed to treat patients with Lewy Body Dementias (LBD), which include Dementia with Lewy Bodies and Parkinson’s Disease Dementia.  Such activities may include identifying trial sites/collaborators, designing trial protocols and procedures, and addressing regulatory approvals.

Leave a Reply